0.1100
-0.0005
(-0.45%)
At close: January 30 at 12:41:14 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-2,933.2940
-2,571.9780
-3,041.4720
-1,013.3040
-4,085.7950
Financing Cash Flow
2,160.9980
2,191.5550
1,367.8410
4,024.0460
3,600.1910
End Cash Position
637.9110
1,026.7990
1,431.7070
3,106.9420
97.2310
Issuance of Capital Stock
--
--
--
150.0000
--
Issuance of Debt
2,553.0000
2,475.0000
1,627.5000
3,160.0000
3,287.5000
Repayment of Debt
-392.0020
-283.4450
-259.6590
-248.1770
-105.9850
Free Cash Flow
-2,933.2940
-2,571.9780
-3,041.4720
-1,013.3040
-4,085.7950
12/31/2020 - 1/15/1997
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TLOG TetraLogic Pharmaceuticals Corporation
0.0001
0.00%
99B0.SG QuiaPEG Pharmaceuticals Holding AB
0.0001
0.00%
FLUO.ST FluoGuide A/S
49.55
+1.75%
ACTI.ST Active Biotech AB (publ)
0.1060
-1.12%
BINV.ST BioInvent International AB (publ)
27.05
0.00%
CANTA.ST Cantargia AB (publ)
1.8490
+1.32%
NRXS NeurAxis, Inc.
2.7100
+0.34%
ENDV Endonovo Therapeutics, Inc.
0.0003
+50.00%
ADXN Addex Therapeutics Ltd
7.31
-6.16%
CASI CASI Pharmaceuticals, Inc.
2.4950
+2.67%